Infectious Complications of Targeted Therapies in Children with Leukemias and Lymphomas

SIMPLE SUMMARY: Targeted therapies in children with hematological malignancies moderate the effects of cytotoxic therapy, thus improving survival rates. They have emerged over the last decade and are used in combination with or after the failure of conventional chemotherapy and as bridging therapy p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kyriakidis, Ioannis, Mantadakis, Elpis, Stiakaki, Eftichia, Groll, Andreas H., Tragiannidis, Athanasios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599435/
https://www.ncbi.nlm.nih.gov/pubmed/36291806
http://dx.doi.org/10.3390/cancers14205022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599435/
https://www.ncbi.nlm.nih.gov/pubmed/36291806
http://dx.doi.org/10.3390/cancers14205022

Ejemplares similares